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To evaluate the role of genetic polymorphisms of NAD(P)H:quinone 
oxidoreductase 1 (NQO1) related to the carcinogen metabolism and 
oxidative status, genotypes of two NQO1 polymorphisms IVS1-27C>G 
and Ex6+40C>T were determined in 616 lung cancer cases and 616 
lung cancer-free controls. When the effect of each NQO1 allele and 
diplotype composed of two NQO1 SNP sites on lung cancer risk was 
evaluated, any NQO1 genotype or diplotype did not show the associa-
tion with lung cancer risk. However, in the analyses of the combined 
effects of smoking and NQO1 diplotype, smokers with other than 
CT/CT diplotype showed signiﬁcantly increased risk of lung cancer 
compared with nonsmoker with other than CT/CT diplotype (adjusted 
OR=2.2, 95% CI, 1.67-3.02) and smokers with CT/CT diplotype 
showed the highest OR of lung cancer (adjusted OR=2.7, 95% CI, 
1.78-4.21). Trend test showed an additive interaction between smok-
ing and NQO1 diplotype (Ptrend<0.01). In the subgroup analyses, the 
additive effect between smoking and NQO1 diplotype was found to be 
more apparent in squamous cell carcinoma although this effect was sta-
tistically signiﬁcant in all lung cancer cell types (NSCLC, Ptrend<0.01; 
AC, Ptrend=0.02; SCC, Ptrend<0.01; other NSCLCs, Ptrend<0.01; and 
SCLC, Ptrend<0.01). This result suggests that haplotypes of NQO1 
gene play an important role in the development of lung cancer by 
producing an additive interaction between smoking and NQO1 gene for 
lung cancer risk.
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Background: Lung cancer is the leading cause of cancer death in the 
United States and Western Europe. Adenocarcinoma, the histological 
subtype most frequently seen in never smokers and former smokers, is 
now the most common type of lung cancer in men and women in the 
United States. The increasing incidence of lung adenocarcinoma and its 
lethal nature underline the importance of understanding the develop-
ment and progression of this disease, and the need for the development 
of accurate tools for early diagnosis. Atypical adenomatous hyperplasia 
(AAH) and bronchioalveolar carcinoma (BAC), deﬁned as non-in-
vasive lesions, are thought to be sequential precursors along the path 
of progression to lung adenocarcinoma. Elucidation of the molecular 
changes underlying the development and progression of lung adenocar-
cinoma is of great importance for devising targeted drugs and methods 
of early detection. DNA hypermethylation at promoter CpG islands is 
now recognized as a key mechanism for tumor suppressor gene inacti-
vation in cancer. Identiﬁcation of abnormal methylation changes could 
provide important insights into the mechanism of cancer development, 
and in addition could yield powerful biomarkers for cancer. 
Methods: Here we use MethyLight®, a sensitive, quantitatively ac-
curate, automated DNA methylation analysis technique to examine 
DNA methylation levels at loci that we have previously shown to be 
highly signiﬁcantly hypermethylated in lung adenocarcinoma compared 
to adjacent non-tumor tissue from the same patient. We examine the 
methylation levels in a unique collection of normal adjacent lung, pre-
invasive lesions (AAH and BAC), mixed adenocarcinoma samples with 
a BAC component, and adenocarcinoma, representing adenocarcinoma 
in its different developmental stages. 
Results: We observe differences in methylation levels for the different 
loci examined, with some loci (such as CDKN2A) showing hypermeth-
ylation already in adjacent non-tumor lung, others (such as SFRP1) 
showing no methylation in normal lung but methylation in AAH and 
BAC/adenocarcinoma, and yet others (such as SFRP5) showing only 
methylation in adenocarcinoma. 
Conclusions: The occurrence of methylation of different loci in distinct 
subsets (normal lung, AAH, BAC, adenocarcinoma) suggests that indi-
vidual loci might be methylated in a temporally distinct fashion during 
developing lung adenocarcinoma. The identiﬁcation of sequential 
epigenetic alterations during progression to lung adenocarcinoma will 
broaden our molecular understanding of the disease, providing insights 
that may be applicable to the development of targeted drugs. Equally 
important, such DNA methylation changes will be powerful markers 
for early detection and patient classiﬁcation. 
P2-018 BSTB: Cancer Genetics Posters, Tue, Sept 4 
Numerical chromosomal aberrations of normal mucosal cells in 
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Background: Small cell and non small cell lung carcinomas exhibit a 
series of chromosomal abnormalities. However, few reports exist con-
cerning the chromosomal alterations of normal bronchial mucosa cells 
of smokers. In the current study, we examined the possible relationship 
of smoking and 3p and other numerical chromosome aberrations of 
normal mucosal cells. 
Methods: Brush cytology samples of 25 patients were available for 
this study, where bronchoscopy was performed for clinical symptoms 
of haemoptysis, dyspnoea, pulmonary inﬁltration etc., but lung cancer 
was not found. Cytological smears were prepared and one H&E stained 
smear was used for cytological examination to rule out dysplasia, 
whereas dual color ﬂuorescent in situ hybridization (FISH) was per-
formed on the others. A mixture of chromosome 3 centromeric probe 
(red) and telomeric 3p probe (green) were used to detect the possible 3p 
deletion or other numerical chromosome alterations.
Results: 10 patients were non-smoker, 9 patients were smoker and 6 
patients were ex-smoker. The ex-smokers had given up smoking 5-31 
years (mean: 8,1 years) before our examination. 4 of 10 smoker patients 
and 3 of 6 ex-smoker patients had signiﬁcantly higher 3p chromosome 
or other numerical aberrations (deletion, monosomy, trisomy) com-
pared to the healthy control (non-smoker) patients. Average percentage 
of chromosomal alteration in non smoker patients was 2.7%. 
